India  

Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin

IndiaTimes Friday, 2 April 2021 ()
Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose six months after second dose.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Watch: Harsh Vardhan takes 2nd dose of Covaxin, says 7 more vaccines in trials

Watch: Harsh Vardhan takes 2nd dose of Covaxin, says 7 more vaccines in trials 05:01

Union Health Minister Harsh Vardhan and his wife Nutan Goel took the second dose of Covid-19 vaccine. Harsh Vardhan and his wife got the vaccine at Delhi Heart and Lung Institute on Tuesday. Both Vardhan and his wife took jabs of indigenously developed Covaxin by Bharat Biotech. The Health Minister...

💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Maharashtra reports 67,123, Karnataka registers 17,489 COVID cases [Video]

Maharashtra reports 67,123, Karnataka registers 17,489 COVID cases

Maharashtra reported 67,123 fresh COVID cases, 56,783 discharges, and 419 deaths on April 17. While Maharashtra's capital reported 8,834 new COVID-19 cases, 6,617 discharges and 52 deaths in last 24 hours. On the other side, Karnataka today registered 17,489 new positive cases, 5,565 discharges and 80 deaths. Kerala also reported 13,835 new cases, 3654 recoveries and 27 deaths today. Meanwhile, Madhya Pradesh reported 11,269 new coronavirus cases, 6,497 recoveries, and 66 deaths in last 24 hours.

Credit: ANI    Duration: 01:22Published
Kiren Rijiju tests positive for COVID-19 [Video]

Kiren Rijiju tests positive for COVID-19

Union Sports Minister Kiren Rijiju has tested positive for COVID-19. He took to Twitter handle and shared the information that he has tested positive for the virus. He is in self-isolation.

Credit: ANI    Duration: 01:04Published

'India defeated COVID-19 last year, can do it again': PM Modi at review meet - Key points

Prime Minister Narendra Modi on Saturday chaired a meeting to review the status of preparedness to handle the ongoing Covid-19 pandemic.
DNA

Drugs Controller General of India Drugs Controller General of India

Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

The Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines..
IndiaTimes

Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccine

Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for..
IndiaTimes

Sputnik V cleared for launch in India: Five things you need to know about Russian vaccine

Following the recommendation of the Drug Controller General of India (DGCI)'s subject expert committee, Russia's anti-Covid vaccine Sputnik V now awaits final..
IndiaTimes

Expert panel clears Sputnik V for ‘emergency use’, drug regulator’s nod expected soon

Amid concerns about the need to step up Covid-19 vaccination, India is soon expected to get its third shot against the infection with the drug regulator’s..
IndiaTimes

Russia hopes approval to Sputnik-V vaccine by DCGI will be completed soon

Russia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it..
IndiaTimes

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes
Nurses share experience after administering COVID vaccine to PM Modi [Video]

Nurses share experience after administering COVID vaccine to PM Modi

Prime Minister Narendra Modi took his second shot of COVID-19 vaccine at AIIMS, Delhi on April 08. He received the first dose of Bharat Biotech's COVAXIN on March 01. "I have given the second dose of COVAXIN to our Prime Minister Narendra Modi today. He spoke to us. It was a memorable moment for me as I got to meet him and vaccinate him," said Nisha Sharma, Nurse. "I am the vaccinator who gave the first dose of COVAXIN to PM Narendra Modi. Today, I got another opportunity to meet him and vaccinate him for the second time. I was elated again. He spoke to us, we even clicked pictures with him," said P Niveda, Nurse. The two nurses who administered COVID-19 vaccine to PM Narendra Modi at AIIMS, Delhi are-P Niveda from Puducherry and Nisha Sharma from Punjab.

Credit: ANI    Duration: 01:16Published

BBV152 BBV152 Vaccine against COVID-19

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

You Might Like


Related videos from verified sources

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months [Video]

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months

Pfizer and BioNTech announced that their ongoing Phase 3 clinical vaccine trial confirms protection for at least six months after the second dose.

Credit: Cover Video STUDIO     Duration: 01:00Published
Gupta: Officials question AstraZeneca vaccine trial results. Here's why [Video]

Gupta: Officials question AstraZeneca vaccine trial results. Here's why

US health officials have expressed concern over AstraZeneca’s announcement on the company’s latest findings from its coronavirus clinical trial. The board said AstraZeneca may have included..

Credit: Bleacher Report AOL     Duration: 02:44Published
Doctor: This is the best news about the AstraZeneca vaccine [Video]

Doctor: This is the best news about the AstraZeneca vaccine

Former Baltimore City Health Commissioner Dr. Leana Wen reacts to the results of a US-based clinical trial that the AstraZeneca Covid-19 vaccine showed 79% efficacy against symptomatic disease.

Credit: Bleacher Report AOL     Duration: 01:02Published

Related news from verified sources

Third dose of Covaxin gets nod for trials, six months after 2nd shot


Indian Express Also reported by •IndiaTimes

COVID-19: At Mulund and Ghatkopar, most beneficiaries choose Covaxin

COVID-19: At Mulund and Ghatkopar, most beneficiaries choose Covaxin
Day 1 of the vaccination for these citizens received a mixed response with less crowds and those preferring one vaccine over the other
Mid-Day

Coronavirus | Government releases names of vaccine expert panel

10-member Subject Expert Committee had cleared Covaxin for restricted emergency use in January
Hindu